Cape fox vs

Vulpes chama compared with Clitopilus passeckerianus

Key Differences

• Cape fox is Least Concern while is Not Evaluated.

Taxonomic Classification

Rank	Cape fox
Kingdom	Animalia (Animals)	Fungi (Fungi)
Phylum	Chordata (Chordates)	Basidiomycota (Club Fungi)
Class	Mammalia (Mammals)	Agaricomycetes (Mushrooms)
Order	Carnivora (Carnivorans)	Agaricales (Gilled Mushrooms)
Family	Canidae (Dogs & Wolves)	Entolomataceae
Genus	Vulpes (Foxes)	Clitopilus
Species	Vulpes chama	Clitopilus passeckerianus

Conservation Status

Cape fox

LC — Least Concern

NE — Not Evaluated

Physical Characteristics

Attribute	Cape fox
Diet	—	—
Average Lifespan	—	—
Average Length	—	—
Average Weight	—	—

Habitat & Geographic Range

Cape fox

Habitat

Typically found in diverse terrestrial and aquatic ecosystems.

Habitat

Typically found in forest floors, decomposing wood, and soil ecosystems.

Range

Distributed across Norway and Sweden.

Cape fox

The Cape fox (Vulpes chama) is a species in the genus Vulpes. It is currently classified as Least Concern on the IUCN Red List. Typically found in diverse terrestrial and aquatic ecosystems.

Clitopilus passeckerianus is a white-rot agaric fungus in the family Entolomataceae notable for its role as a natural producer of pleuromutilin, a diterpenoid antibiotic compound that serves as the biosynthetic precursor for the veterinary and human antibiotic drugs tiamulin and valnemulin, used to treat Mycoplasma infections in livestock. First described from European woodland habitats, the species produces the characteristic Clitopilus fruiting body: a pale, whitish cap with decurrent, crowded gills becoming pinkish at maturity from angular spores, and a farinaceous odor. Its antibiotic-producing capacity makes C. passeckerianus of significant pharmaceutical interest, and biosynthetic studies of pleuromutilin production have informed synthetic chemistry approaches to antibiotic development. The species inhabits temperate deciduous woodland floors in Europe, fruiting in autumn among leaf litter. Discovery of its pleuromutilin biosynthetic pathway has opened avenues for heterologous expression and semi-synthetic modification aimed at developing novel antibiotics to counter antibiotic-resistant bacterial pathogens.